Efficacy and Safety of an Ophthalmic DMPC-Based Nanoemulsion in Patients with Dry Eye Disease: A Phase I/II Randomized Clinical Trial

PURPOSE: The goals of this study were to evaluate the safety and efficacy of an ophthalmic 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)-based nanoemulsion (Nanodrop®) in patients with dry eye disease (DED). METHODS: This was a randomized phase I/II multicentric, prospective, double-blind clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Baiza-Durán, Leopoldo M., Muñoz-Villegas, Patricia, Sánchez-Ríos, Alejandra, Olvera-Montaño, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110385/
https://www.ncbi.nlm.nih.gov/pubmed/37077305
http://dx.doi.org/10.1155/2023/1431473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110385/
https://www.ncbi.nlm.nih.gov/pubmed/37077305
http://dx.doi.org/10.1155/2023/1431473

Ejemplares similares